Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,173	627	690	707	503	812
Market Cap Growth	98.52%	-9.08%	-2.41%	40.66%	-38.05%	-17.99%
Enterprise Value	1,143	587	658	657	487	787
Last Close Price	16.80	9.10	10.10	10.20	7.25	-
PE Ratio	3602.73	-	-	55.27	35.75	26.30
PS Ratio	3.80	2.19	3.11	3.68	2.88	4.68
PB Ratio	5.20	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	10.61	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	26.10	-	-	35.85	21.10	12.57
P/OCF Ratio	25.81	-	-	33.66	15.11	11.87
EV/Sales Ratio	3.70	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	26.54	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	32.95	-	-	67.70	23.07	12.62
EV/FCF Ratio	25.44	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.50	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	2.55	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	2.48	-	-	7.91	5.97	2.05
Asset Turnover	0.81	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.57	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.39	2.96	3.28	3.90	4.69	3.09
Current Ratio	3.16	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	0.03%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	5.76%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Invested Capital (ROIC)	0.08%	-2.10%	-12.76%	5.79%	10.98%	54.07%
Return on Capital Employed (ROCE)	10.70%	-1.10%	-5.70%	2.80%	6.80%	22.30%
Earnings Yield	0.03%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	3.83%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	2.65%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.